These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 16356695)

  • 21. Weight change after an atypical antipsychotic switch.
    Ried LD; Renner BT; Bengtson MA; Wilcox BM; Acholonu WW
    Ann Pharmacother; 2003 Oct; 37(10):1381-6. PubMed ID: 14519048
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Data on diabetes from the French cohort study in schizophrenia.
    Philippe A; Vaiva G; Casadebaig F
    Eur Psychiatry; 2005 Dec; 20 Suppl 4():S340-4. PubMed ID: 16459248
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of atypical antipsychotics and the risk of breast cancer.
    Azoulay L; Yin H; Renoux C; Suissa S
    Breast Cancer Res Treat; 2011 Sep; 129(2):541-8. PubMed ID: 21479550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Atypical antipsychotics and new onset diabetes mellitus. An overview of the literature.
    Cohen D
    Pharmacopsychiatry; 2004 Jan; 37(1):1-11. PubMed ID: 14750042
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk of discontinuation of atypical antipsychotic agents in the treatment of schizophrenia.
    Mullins CD; Obeidat NA; Cuffel BJ; Naradzay J; Loebel AD
    Schizophr Res; 2008 Jan; 98(1-3):8-15. PubMed ID: 17596914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disturbed glucose metabolism among patients taking olanzapine and typical antipsychotics.
    Dunlop BW; Sternberg M; Phillips LS; Andersen J; Duncan E
    Psychopharmacol Bull; 2003; 37(3):99-117. PubMed ID: 14608243
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atypical antipsychotics and parkinsonism.
    Rochon PA; Stukel TA; Sykora K; Gill S; Garfinkel S; Anderson GM; Normand SL; Mamdani M; Lee PE; Li P; Bronskill SE; Marras C; Gurwitz JH
    Arch Intern Med; 2005 Sep; 165(16):1882-8. PubMed ID: 16157833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploring the association between atypical neuroleptic agents and diabetes mellitus in older adults.
    Etminan M; Streiner DL; Rochon PA
    Pharmacotherapy; 2003 Nov; 23(11):1411-5. PubMed ID: 14620387
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment with antipsychotics and the risk of diabetes in clinical practice.
    Kessing LV; Thomsen AF; Mogensen UB; Andersen PK
    Br J Psychiatry; 2010 Oct; 197(4):266-71. PubMed ID: 20884948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Schizophrenia patients at higher risk of diabetes, hypertension and hyperlipidemia: a population-based study.
    Liao CH; Chang CS; Wei WC; Chang SN; Liao CC; Lane HY; Sung FC
    Schizophr Res; 2011 Mar; 126(1-3):110-6. PubMed ID: 21216567
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association Between Urinary Tract Infections and Antipsychotic Drug Use in Older Adults.
    van Strien AM; Souverein PC; Keijsers CJPW; Heerdink ER; Derijks HJ; van Marum RJ
    J Clin Psychopharmacol; 2018 Aug; 38(4):296-301. PubMed ID: 29894393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Frequency of new-onset diabetes mellitus and use of antipsychotic drugs among Central Texas veterans.
    Barner JC; Worchel J; Yang M
    Pharmacotherapy; 2004 Nov; 24(11):1529-38. PubMed ID: 15537558
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnoses associated with use of atypical antipsychotics in a commercial health plan: a claims database analysis.
    Citrome L; Kalsekar I; Guo Z; Laubmeier K; Hebden T
    Clin Ther; 2013 Dec; 35(12):1867-75. PubMed ID: 24119767
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk of cerebrovascular adverse events in older adults using antipsychotic agents: a propensity-matched retrospective cohort study.
    Mehta S; Johnson ML; Chen H; Aparasu RR
    J Clin Psychiatry; 2010 Jun; 71(6):689-98. PubMed ID: 20573328
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antipsychotics and the risk of type 2 diabetes mellitus in children and youth.
    Bobo WV; Cooper WO; Stein CM; Olfson M; Graham D; Daugherty J; Fuchs DC; Ray WA
    JAMA Psychiatry; 2013 Oct; 70(10):1067-75. PubMed ID: 23965896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolic and cardiovascular adverse events associated with antipsychotic treatment in children and adolescents.
    McIntyre RS; Jerrell JM
    Arch Pediatr Adolesc Med; 2008 Oct; 162(10):929-35. PubMed ID: 18838645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antipsychotics and diabetes: an age-related association.
    Hammerman A; Dreiher J; Klang SH; Munitz H; Cohen AD; Goldfracht M
    Ann Pharmacother; 2008 Sep; 42(9):1316-22. PubMed ID: 18664607
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of adiponectin and metabolic syndrome among patients taking atypical antipsychotics for schizophrenia: a cohort study.
    Bai YM; Chen TT; Yang WS; Chi YC; Lin CC; Liou YJ; Wang YC; Su TP; Chou P; Chen JY
    Schizophr Res; 2009 Jun; 111(1-3):1-8. PubMed ID: 19409756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diabetes risk associated with use of olanzapine, quetiapine, and risperidone in veterans health administration patients with schizophrenia.
    Lambert BL; Cunningham FE; Miller DR; Dalack GW; Hur K
    Am J Epidemiol; 2006 Oct; 164(7):672-81. PubMed ID: 16943266
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Time to psychiatric hospitalization in patients with bipolar disorder treated with a mood stabilizer and adjunctive atypical antipsychotics: a retrospective claims database analysis.
    Kim E; Maclean R; Ammerman D; Jing Y; Pikalov A; You M; Van-Tran Q; L'Italien G
    Clin Ther; 2009 Apr; 31(4):836-48. PubMed ID: 19446157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.